Satellos Bioscience Inc. Common Stock

MSLE XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

200M

Short interest (Jul 15)

0.5%

Net Short (Jul 27 ): 0.0%

Borrow Fee

4.55%

↓ 3.8%

Available Shares

400K

↓ 9.3%

Price Chart

Company Overview

Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.

Company Info

Exchange: NASDAQ

CIK: 0001421642

Asset Type: CS

Market Data

Market Cap: $203,729,038

Employees: 21

Status: Active

Short Interest

Current Borrow Fee 4.55%

Range: 4.24% - 4.55%

Available Shares 400K

Range: 300K - 350K

Recent Changes

Fee Change: ↓ 6.5%

Available Change: ↑ 8.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime